Your browser doesn't support javascript.
loading
High-Density Lipoprotein Composition Influences Lymphatic Transport after Subcutaneous Administration.
Gracia, Gracia; Cao, Enyuan; Feeney, Orlagh M; Johnston, Angus P R; Porter, Christopher J H; Trevaskis, Natalie L.
Affiliation
  • Gracia G; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne 3052, Australia.
  • Cao E; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne 3052, Australia.
  • Feeney OM; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne 3052, Australia.
  • Johnston APR; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne 3052, Australia.
  • Porter CJH; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne 3052, Australia.
  • Trevaskis NL; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne 3052, Australia.
Mol Pharm ; 17(8): 2938-2951, 2020 08 03.
Article in En | MEDLINE | ID: mdl-32543863
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Biological Transport / Lymphatic Vessels / Lipoproteins, HDL Limits: Adolescent / Adult / Aged / Animals / Female / Humans / Male / Middle aged Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Biological Transport / Lymphatic Vessels / Lipoproteins, HDL Limits: Adolescent / Adult / Aged / Animals / Female / Humans / Male / Middle aged Language: En Year: 2020 Type: Article